134 related articles for article (PubMed ID: 3986811)
21. Serum ferritin as a prognostic indicator in neuroblastoma: biological effects of isoferritins.
Hann HW; Stahlhut MW; Evans AE
Prog Clin Biol Res; 1985; 175():331-45. PubMed ID: 3873075
[TBL] [Abstract][Full Text] [Related]
22. Neuroblastoma--a surgical perspective.
Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
[TBL] [Abstract][Full Text] [Related]
23. Pattern and outcome of neuroblastoma. A 10 year study.
Kusumakumary P; Ajithkumar TV; Ratheesan K; Chellam VG; Nair MK
Indian Pediatr; 1998 Mar; 35(3):223-9. PubMed ID: 9707875
[TBL] [Abstract][Full Text] [Related]
24. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
[TBL] [Abstract][Full Text] [Related]
25. Source of increased ferritin in neuroblastoma: studies with concanavalin A-sepharose binding.
Hann HW; Stahlhut MW; Evans AE
J Natl Cancer Inst; 1986 Jun; 76(6):1031-3. PubMed ID: 3458940
[TBL] [Abstract][Full Text] [Related]
26. Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.
Mora J; Cheung NK; Chen L; Qin J; Gerald W
Cancer; 2001 Jan; 91(2):435-42. PubMed ID: 11180092
[TBL] [Abstract][Full Text] [Related]
27. Varicella zoster virus infections in neuroblastoma patients: a 31-year clinical study.
Izbicki T; Mazur J; Izbicka E
Anticancer Res; 2003; 23(3C):3061-8. PubMed ID: 12926162
[TBL] [Abstract][Full Text] [Related]
28. Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol.
Olgun N; Kansoy S; Aksoylar S; Cetingul N; Vergin C; Oniz H; Sarialioglu F; Kantar M; Uysal K; Tuncyurek M; Kargi A; Aktas S; Bayol U; Karaca I; Arikan A; Balik E; Aktug T; Elmas N; Kovanlikaya A; Kinay M; Anacak Y; Degirmenci B; Burak Z
Pediatr Hematol Oncol; 2003; 20(3):211-8. PubMed ID: 12637217
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in neuroblastoma.
Kajanti M; Holsti P
Ann Clin Res; 1986; 18(3):129-33. PubMed ID: 3740789
[TBL] [Abstract][Full Text] [Related]
30. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
[TBL] [Abstract][Full Text] [Related]
31. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.
Atra A; Imeson JD; Hobson R; Gerrard M; Hann IM; Eden OB; Carter RL; Pinkerton CR
Br J Cancer; 2000 Apr; 82(8):1396-402. PubMed ID: 10780517
[TBL] [Abstract][Full Text] [Related]
32. Neuroblastoma in 88 children. Clinical features, prognostic factors, results and late effects of therapy.
Kajanti M
Ann Clin Res; 1983; 15 Suppl 39():1-68. PubMed ID: 6670848
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
34. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
Fukuda M; Nozaki C; Ishiguro Y; Horibe K
Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
[TBL] [Abstract][Full Text] [Related]
35. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
36. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
37. Serum ferritin in stage IV neuroblastoma.
Imashuku S; Yamanaka H; Morioka Y; Todo S
Am J Pediatr Hematol Oncol; 1988; 10(1):39-41. PubMed ID: 3189716
[TBL] [Abstract][Full Text] [Related]
38. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang DC; Wang F; Elliott RL; Head JF
Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
[TBL] [Abstract][Full Text] [Related]
39. [Neuroblastoma: prognostic factors and survival. Experience in Hospital de Pediatria del Centro Medico Nacional del Siglo XXI and review of the literature].
López-Aguilar E; Cerecedo-Díaz F; Rivera-Márquez H; Valdéz-Sánchez M; Sepúlveda-Vildósola AC; Delgado Huerta S; Vera-Hermosillo H; Vázquez-Langle JR; Wanzke del Angel V
Gac Med Mex; 2003; 139(3):209-14. PubMed ID: 12872413
[TBL] [Abstract][Full Text] [Related]
40. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
